Literature DB >> 3490974

Beta-lactamase production in the upper respiratory tract flora.

I Eliasson, C Kamme, K Prellner.   

Abstract

In order to determine the recovery rate of species of the genera Haemophilus and Moraxella (including subgenus Branhamella) from the upper respiratory tract and the incidence of beta-lactamase production within these genera, cultures were made of nose and throat swab specimens and adenoid tissue in 50 children undergoing adenoidectomy. Haemophilus influenzae was isolated from 92% of the children. All children harboured strains of Haemophilus spp. and in 46%, at least one strain produced the TEM-1 beta-lactamase. Branhamella catarrhalis and/or Moraxella nonliquefaciens were isolated from 82% of the children and strains producing the BRO-1 beta-lactamase from 34%. Overall, TEM-1 and/or BRO-1 producing strains were recovered from 60% of the investigated patients. The beta-lactamase production was found to be transferable by conjugation within the respective genera. It is suggested that the apathogenic species may be a source of transferable determinants mediating beta-lactamase production in the upper respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490974     DOI: 10.1007/BF02017692

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  29 in total

1.  A rapid method for the differentiation of Haemophilus strains. The porphyrin test;.

Authors:  M Kilian
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-12

2.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

3.  Characterization of ampicillin-resistant Haemophilus parainfluenzae.

Authors:  D W Scheifele; S J Fussell; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

4.  Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

Authors:  A Percival; J E Corkill; J Rowlands; R B Sykes
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

5.  Susceptibility in vitro of Haemophilus influenzae to penicillin G, penicillin V and ampicillin. Incubation of strains from acute otitis media in air and in CO2-atmosphere.

Authors:  C Kamme
Journal:  Acta Pathol Microbiol Scand       Date:  1969

6.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

7.  Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase.

Authors:  L G Rubin; A A Medeiros; R H Yolken; E R Moxon
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

8.  Bacterial adherence to epithelial cells in the nasopharynx in children.

Authors:  C Lundberg; J Lönnroth
Journal:  Acta Otolaryngol       Date:  1979       Impact factor: 1.494

9.  Betalactamase-producing microorganisms in recurrent tonsillitis.

Authors:  K Tunér; C E Nord
Journal:  Scand J Infect Dis Suppl       Date:  1983

10.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

Authors:  P A Shurin; C D Marchant; C H Kim; G F Van Hare; C E Johnson; M A Tutihasi; L J Knapp
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb
View more
  8 in total

1.  Circulation in Italy of beta-lactamase-producing strains within the major groups of bacterial pathogens.

Authors:  P E Varaldo; G Nicoletti; G C Schito; A Maida; B Facinelli; S Stefani; G Gianrossi; E Muresu
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

2.  Direct and indirect pathogenicity of beta-lactamase-producing bacteria in respiratory tract infection in children. Role of cephalosporins resistant to enzymatic hydrolysis.

Authors:  S Stefani; M B Pellegrino; G Russo; G Nicoletti
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; B Weise; A M Van den Abeele
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.

Authors:  I Eliasson; C Kamme; M Vang; S G Waley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

7.  Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis.

Authors:  E R Brankston; H S Conter; R Corriveau; J M Martel; C Laroche; R Roy; C Savard; D Roy; R Kelly; P Forget; M Rivard; F Boulerice
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

8.  Down-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillins.

Authors:  Marion Jetter; Violeta Spaniol; Rolf Troller; Christoph Aebi
Journal:  J Antimicrob Chemother       Date:  2010-08-27       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.